Intraperitoneal Injection Improves the Uptake of Nanoparticle-Labeled High-Density Lipoprotein to Atherosclerotic Plaques Compared With Intravenous Injection
Author(s) -
Caroline Jung,
Michael G. Kaul,
Oliver T. Bruns,
Tanja Dučić,
Barbara Freund,
Markus Heine,
Rudolph Reimer,
Alke Meents,
Sunhild C. Salmen,
Horst Weller,
Peter Brønnum Nielsen,
Gerhard Adam,
Jörg Heeren,
Harald Ittrich
Publication year - 2013
Publication title -
circulation cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.584
H-Index - 99
eISSN - 1942-0080
pISSN - 1941-9651
DOI - 10.1161/circimaging.113.000607
Subject(s) - ex vivo , in vivo , biodistribution , intraperitoneal injection , fluorescence microscope , pathology , fluorescence lifetime imaging microscopy , preclinical imaging , confocal microscopy , medicine , chemistry , nuclear medicine , fluorescence , pharmacology , biology , physics , microbiology and biotechnology , quantum mechanics
The aim of this study was to assess whether high-density lipoprotein (HDL) labeled with superparamagnetic iron oxide nanoparticles (SPIOs) and quantum dots was able to detect atherosclerotic lesions in mice after intravenous and intraperitoneal injection by multimodal imaging.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom